Research into treatments for neuromuscular diseases has progressed enormously in recent years. For many of our diseases, potential treatments are now under investigation either in laboratories or in the clinic. MDA-sponsored research has either directly or indirectly resulted in most of the potential treatments that are now in development. Click on any of the diseases below to find out about latest research into that disease, as well as to learn more about the potential treatments being studied.
Even studies that are not currently being funded by MDA are based on basic research into muscle and nerve biology, the causes of the diseases and basic technologies, that have been funded by MDA for decades. To find out more about how MDA sponsors research, go to our section about the Funding Process.
Be sure to visit What Has MDA Achieved? to learn more about MDA's research progress.
Carnitine Palmityl Transferase Deficiency (CPT Deficiency)
Central Core Disease (CCD)
Congenital Muscular Dystrophy (CMD)
Congenital Myasthenic Syndromes (CMS)
Congenital Myotonic Dystrophy
Cori Disease (Debrancher Enzyme Deficiency)
McArdle Disease (Phosphorylase Deficiency)
Merosin-Deficient Congenital Muscular Dystrophy
Metabolic Diseases of Muscle
Miyoshi Distal Myopathy
Motor Neurone Disease
Muscle-Eye-Brain Disease (CMD)
Myasthenia Gravis (MG)
Myoadenylate Deaminase Deficiency
Myofibrillar Myopathy (LGMD)
Myotonia Congenita (MC)
Myotonic Muscular Dystrophy (MMD)
Myotubular Myopathy (MTM or MM)
Peroneal Muscular Atrophy (CMT)
Phosphoglycerate Kinase Deficiency
Phosphoglycerate Mutase Deficiency
Pompe Disease (AMD)
Progressive External Ophthalmoplegia (PEO)
Rod Body Disease (Nemaline Myopathy)
ZASP-Related Myopathy (LGMD)
Muscular Dystrophy Association — USA
222 S. Riverside Plaza, Suite 1500
Chicago, Illinois 60606
The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization.
©2015, Muscular Dystrophy Association Inc. All rights reserved.